These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34121360)

  • 1. Preinfection laboratory parameters may predict COVID-19 severity in tumor patients.
    Kiani A; Roesch R; Wendtner CM; Kullmann F; Kubin T; Südhoff T; Augustin M; Schaich M; Müller-Naendrup C; Illerhaus G; Hartmann F; Hebart H; Seggewiss-Bernhardt R; Bentz M; Späth-Schwalbe E; Reimer P; Kaiser U; Kapp M; Graeven U; Chemnitz JM; Baesecke J; Lambertz H; Naumann R
    Cancer Med; 2021 Jul; 10(13):4424-4436. PubMed ID: 34121360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome.
    Lee RJ; Wysocki O; Bhogal T; Shotton R; Tivey A; Angelakas A; Aung T; Banfill K; Baxter M; Boyce H; Brearton G; Copson E; Dickens E; Eastlake L; Gomes F; Hague C; Harrison M; Horsley L; Huddar P; Hudson Z; Khan S; Khan UT; Maynard A; McKenzie H; Palmer D; Robinson T; Rowe M; Thomas A; Tweedy J; Sheehan R; Stockdale A; Weaver J; Williams S; Wilson C; Zhou C; Dive C; Cooksley T; Palmieri C; Freitas A; Armstrong AC
    ESMO Open; 2021 Feb; 6(1):100005. PubMed ID: 33399072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study.
    Mukkada S; Bhakta N; Chantada GL; Chen Y; Vedaraju Y; Faughnan L; Homsi MR; Muniz-Talavera H; Ranadive R; Metzger M; Friedrich P; Agulnik A; Jeha S; Lam C; Dalvi R; Hessissen L; Moreira DC; Santana VM; Sullivan M; Bouffet E; Caniza MA; Devidas M; Pritchard-Jones K; Rodriguez-Galindo C;
    Lancet Oncol; 2021 Oct; 22(10):1416-1426. PubMed ID: 34454651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic and features of SARS-CoV-2 infection in Gabon.
    Mveang Nzoghe A; Padzys GS; Maloupazoa Siawaya AC; Kandet Yattara M; Leboueny M; Avome Houechenou RM; Bongho EC; Mba-Mezeme C; Mvoundza Ndjindji O; Biteghe-Bi-Essone JC; Boulende A; Essone PN; Ndong Sima CAA; Minkobame U; Zang Eyi C; Ndeboko B; Voloc A; Meye JF; Ategbo S; Djoba Siawaya JF
    Sci Rep; 2021 May; 11(1):9672. PubMed ID: 33958601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
    Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
    Front Immunol; 2021; 12():700921. PubMed ID: 34539631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Age With Likelihood of Developing Symptoms and Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection in Italy.
    Poletti P; Tirani M; Cereda D; Trentini F; Guzzetta G; Sabatino G; Marziano V; Castrofino A; Grosso F; Del Castillo G; Piccarreta R; Andreassi A; Melegaro A; Gramegna M; Ajelli M; Merler S;
    JAMA Netw Open; 2021 Mar; 4(3):e211085. PubMed ID: 33688964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between hematological parameters and disease severity in patients with SARS-CoV-2 infection.
    Lin S; Mao W; Zou Q; Lu S; Zheng S
    J Clin Lab Anal; 2021 Jan; 35(1):e23604. PubMed ID: 33184946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative.
    Bennett TD; Moffitt RA; Hajagos JG; Amor B; Anand A; Bissell MM; Bradwell KR; Bremer C; Byrd JB; Denham A; DeWitt PE; Gabriel D; Garibaldi BT; Girvin AT; Guinney J; Hill EL; Hong SS; Jimenez H; Kavuluru R; Kostka K; Lehmann HP; Levitt E; Mallipattu SK; Manna A; McMurry JA; Morris M; Muschelli J; Neumann AJ; Palchuk MB; Pfaff ER; Qian Z; Qureshi N; Russell S; Spratt H; Walden A; Williams AE; Wooldridge JT; Yoo YJ; Zhang XT; Zhu RL; Austin CP; Saltz JH; Gersing KR; Haendel MA; Chute CG;
    JAMA Netw Open; 2021 Jul; 4(7):e2116901. PubMed ID: 34255046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remdesivir for the treatment of COVID-19.
    Grundeis F; Ansems K; Dahms K; Thieme V; Metzendorf MI; Skoetz N; Benstoem C; Mikolajewska A; Griesel M; Fichtner F; Stegemann M
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD014962. PubMed ID: 36695483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte blood levels that remain low can predict the death of patients with COVID-19.
    Zhang HJ; Qi GQ; Gu X; Zhang XY; Fang YF; Jiang H; Zhao YJ
    Medicine (Baltimore); 2021 Jul; 100(28):e26503. PubMed ID: 34260527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of SARS-CoV-2 infection in 126 children and adolescents with central nervous system tumors.
    Moreira DC; Qaddoumi I; Chen Y; Bhakta N; Chantada GL; Santana VM; Caniza MA; Devidas M; Pritchard-Jones K; Rodriguez-Galindo C; Bouffet E; Mukkada S;
    Pediatr Blood Cancer; 2023 Aug; 70(8):e30402. PubMed ID: 37194498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of patients infected with SARS-CoV-2 in North Wollo Zone, North-East Ethiopia.
    Geteneh A; Alemnew B; Tadesse S; Girma A
    Pan Afr Med J; 2021; 38():217. PubMed ID: 34046123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors that predict severity of infection and seroconversion in immunocompromised children and adolescents with COVID-19 infection.
    Abu Shanap M; Sughayer M; Alsmadi O; Elzayat I; Al-Nuirat A; Tbakhi A; Sultan I
    Front Immunol; 2022; 13():919762. PubMed ID: 35990639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 in pediatric cancer patients is associated with treatment interruptions but not with short-term mortality: a Polish national study.
    Węcławek-Tompol J; Zakrzewska Z; Gryniewicz-Kwiatkowska O; Pierlejewski F; Bień E; Zaucha-Prażmo A; Zając-Spychała O; Szmydki-Baran A; Mizia-Malarz A; Bal W; Sawicka-Żukowska M; Kruk A; Ociepa T; Raciborska A; Książek A; Szczepański T; Peregud-Pogorzelski J; Krawczuk-Rybak M; Chaber R; Matysiak M; Wachowiak J; Irga-Jaworska N; Młynarski W; Dembowska-Bagińska B; Balwierz W; Matkowska-Kocjan A; Kazanowska B; Styczyński J; Ussowicz M
    J Hematol Oncol; 2021 Oct; 14(1):163. PubMed ID: 34635137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.
    Fu J; Kong J; Wang W; Wu M; Yao L; Wang Z; Jin J; Wu D; Yu X
    Thromb Res; 2020 Aug; 192():3-8. PubMed ID: 32407937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients.
    Elshazli RM; Toraih EA; Elgaml A; El-Mowafy M; El-Mesery M; Amin MN; Hussein MH; Killackey MT; Fawzy MS; Kandil E
    PLoS One; 2020; 15(8):e0238160. PubMed ID: 32822430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.